SAGA
Desconocido
TIGER: Proof of Principle of the best in class therapeutic mRNA cancer vaccine
SAGA DIAGNOSTICS AB
participó en un
H2020:
H2020-SC1-BHC-2018-2020
TIGER delivers proof of principle (PoP) in humans for a novel best-in-class therapeutic mRNA cancer vaccine platform optimized for intraveno...
2021-02-15 - 2025-07-31 | Financiado
2021-02-15 - 2025-07-31 | Financiado
EXACT-dna: EXtended Analysis of Circulating Tumour DNA to improve cancer management strategies
SAGA DIAGNOSTICS AB
tramitó un
H2020:
H2020-SMEInst-2016-2017
Through the EXACT-dna project, SAGA Diagnostics (SAGA Dx), intends to clinically validate and commercialize two distinct technologies, IBSAF...
2017-11-30 - 2018-05-31 | Financiado
2017-11-30 - 2018-05-31 | Financiado
* No se disponen de datos de la empresa actual.